FMP
Jul 26, 2024 9:44 AM - Davit Kirakosyan
Dexcom (NASDAQ:DXCM) significantly revised its guidance downward after its second-quarter revenue failed to meet expectations, citing weaker execution of essential strategies. Following this announcement, the company's shares plummeted over 36% in pre-market today.
The diabetes management firm adjusted its revenue forecast to a range of $4.00 billion to $4.05 billion, a reduction from the previously anticipated $4.20 billion to $4.35 billion.
Dexcom acknowledged that although it made progress on several key strategic initiatives during the second quarter, its overall execution fell short of its rigorous standards.
For the second quarter, Dexcom reported earnings of $0.43 per share on revenue of $1.00 billion, compared to the analysts' expectations of $0.39 per share on revenue of $1.04 billion.
Looking ahead to the third quarter, the company provided a revenue guidance range of $975 million to $1.00 billion, which is below the Street estimate of $1.15 billion.
Jan 16, 2024 4:18 PM - Samuel Abdelshahid
In the hustle and bustle of the trading world, having a trustworthy laptop is like having a reliable partner by your side. Making well-informed decisions and staying ahead of market trends become second nature with the right device. However, the quest for a budget-friendly trading laptop t...
Jan 21, 2024 4:00 AM - Parth Sanghvi
Introduction: In the world of financial analysis, a profound grasp of essential profitability metrics is vital. This blog delves into three pivotal metrics—ROE (Return on Equity), ROA (Return on Assets), and Net Profit Margin—offering clear insights without unnecessary complexity. Exploring RO...
May 14, 2024 11:41 AM - Sanzhi Kobzhan
A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...